Immix Biopharma, Inc. IMMX Increase (Decrease) in Prepaid Expense and Other Assets
Increase (Decrease) in Prepaid Expense and Other Assets at other companies
Other financials
Where this comes from
Reported directly by Immix Biopharma, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.
The official record: Immix Biopharma, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Immix Biopharma, Inc.'s increase (decrease) in prepaid expense and other assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Immix Biopharma, Inc.'s increase (decrease) in prepaid expense and other assets?
- Immix Biopharma, Inc. (IMMX) reported increase (decrease) in prepaid expense and other assets of $866.6K in Q1 2026.
- How has Immix Biopharma, Inc.'s increase (decrease) in prepaid expense and other assets changed year-over-year?
- Immix Biopharma, Inc.'s increase (decrease) in prepaid expense and other assets increased by 173.7% year-over-year, from $316.62K to $866.6K.
- What is the long-term trend for Immix Biopharma, Inc.'s increase (decrease) in prepaid expense and other assets?
- Over 2 years (2021 to 2024), Immix Biopharma, Inc.'s increase (decrease) in prepaid expense and other assets has grown at a 5.0% compound annual growth rate (CAGR), from $502.8K to -$554.77K.
- What does increase (decrease) in prepaid expense and other assets mean?
- This tracks changes in cash paid in advance for goods or services that will be consumed in future periods. It reflects the timing difference between cash outflows and the recognition of related expenses on the income statement.